Special Issue "Machine Learning for Molecular Modelling in Drug Design"
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: closed (25 September 2018).
Interests: structure bioinformatics; cancer pharmaco-omics modelling; biomarker discovery; precision oncology; chemoinformatics; drug discovery informatics; virtual screening; machine learning
Machine Learning (ML) has become a crucial component of early drug discovery. This research area has been fuelled by two main factors. The first is the fast-growing availability of relevant experimental data. Examples of such data are bioactivities between molecules of known chemical structure and non-molecular targets (cell lines, mice models, etc.), binding affinities of such molecules against macromolecular targets or X-ray crystal structures of proteins acting as drug targets. This trend has been catalysed by the development of community resources (e.g., ChEMBL, PubChem or PDB to name a few) that curate and facilitate re-using these data sets for predictive modelling. The second factor is the easy access to high-quality implementations in R or Python of a range of ML algorithms, along with the continuous introduction of new advances (e.g., XGBoost, deep learning or conformal prediction). As a result, an increasing number of data-driven ML models are being proposed and found advantageous in some way to identify new starting points for the drug discovery process.
We invite scientists working on this area to submit their original research or review articles for publication in this Special Issue. Topics of interest include (but are not limited to) docking, QSAR, target prediction, virtual screening or lead optimization. Both application and methodology research studies are welcome.
Dr. Pedro J. Ballester
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Predictive modelling
- Virtual screening
- Lead optimization
- Target prediction
- Drug design